Your browser doesn't support javascript.
loading
Expression profile of KIR3DS1/KIR3DL1 receptors in association with immunological responses in TB, HIV and HIV/TB infected patients.
Shaukat, Sobia Naz; Nasir, Faizan; Raza, Afsheen; Khanani, Rafiq; Uddin, Shahab; Kazmi, Shahana Urooj.
Affiliation
  • Shaukat SN; Department of Microbiology, Karachi University, Karachi, Pakistan; Aga Khan University Hospital, Karachi, Pakistan. Electronic address: sobia.naz@aku.edu.
  • Nasir F; Department of Immunology, Dadabhoy Institute of Higher Education, Karachi, Pakistan. Electronic address: faizannasir@gmail.com.
  • Raza A; College of Health Sciences, Abu Dhabi University, PO Box 59911, Abu Dhabi, United Arab Emirates. Electronic address: raza.afsheen@adu.ac.ae.
  • Khanani R; Dow University of Health Sciences, Ojha Campus, Karachi, Pakistan. Electronic address: rafiqcitilab@gmail.com.
  • Uddin S; Translational Research Institute and Dermatology Institute, Academic Health System, Hamad, Medical Corporation, Doha, Qatar; Laboratory Animal Research Center, Qatar University, Doha, Qatar. Electronic address: SKhan34@hamad.qa.
  • Kazmi SU; Department of Microbiology, Karachi University, Karachi, Pakistan. Electronic address: shahanaurooj@yahoo.com.
Microb Pathog ; 180: 106145, 2023 Jul.
Article de En | MEDLINE | ID: mdl-37169313
ABSTRACT
Several studies investigated KIR3DS1 and KIR3DL1 in the context of various infections. However, none of the studies were performed on KIR3DS1/L1 in association with IFN-É£/IL-10 in TB, HIV-1, and their confections. We aimed to evaluate KIR3DS1/KIR3DL1 expression in association with IFNÉ£/IL-10 in HIV-1 and TB mono-infections and HIV-1/TB confection and compared with uninfected controls using RTq PCR. We also performed correlation analysis between KIR3DS1, KIR3DL1, IFN-É£ and IL-10 in the respective cohorts. The overall expression of KIR3DS1 was found to be downregulated in all groups, whereas in HIV-1 and HIV-1/TB, the frequency of KIR3DS1(+) expression was significantly (p < 0.05) associated with undetected HIV-1 viral load. However, expression of KIR3DL1 was found to be significantly (p < 0.05) upregulated in HIV-1 only. In addition, IFNÉ£ expression was significantly (p < 0.05) decreased in TB, whereas in HIV-1/TB, IFNÉ£ expression was significantly (p < 0.05) increased. In contrast, IL-10 expression was significantly (p < 0.05) increased in HIV-1 and HIV-1/TB but not in TB. Also, we found significant positive correlation (p < 0.05, r = 0.61) between KIR3DL1 and IFNÉ£ expression in TB and negative correlation (p < 0.05, r = - 0.62) between KIR3DS1 and IL-10 in HIV-1/TB. In conclusion, we suggest that expression of KIR3DS1/L1 is associated with IFNÉ£/IL-10 responses and it is involved in modulating disease severity in HIV-1 and TB infections.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tuberculose / Infections à VIH / VIH-1 (Virus de l&apos;Immunodéficience Humaine de type 1) Type d'étude: Risk_factors_studies Limites: Humans Langue: En Journal: Microb Pathog Sujet du journal: DOENCAS TRANSMISSIVEIS / MICROBIOLOGIA Année: 2023 Type de document: Article

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tuberculose / Infections à VIH / VIH-1 (Virus de l&apos;Immunodéficience Humaine de type 1) Type d'étude: Risk_factors_studies Limites: Humans Langue: En Journal: Microb Pathog Sujet du journal: DOENCAS TRANSMISSIVEIS / MICROBIOLOGIA Année: 2023 Type de document: Article